Eris Lifesciences, an Ahmedabad-based company, on Thursday has raised Rs 779.43 Crore from anchor investors ahead of its Rs 1,800 crore initial public offer (IPO).
The IPO issue size stands at 1,59,48,750 shares. Total bids received as of 11:30 AM stood at 29,37,720 shares and total bids received at cut off price stood at 17,89,872 shares, as per the data available with National Stock Exchange (NSE)
The IPO issue size stands at 1,59,48,750 shares. Total bids received as of 11:30 AM stood at 29,37,720 shares and total bids received at cut off price stood at 17,89,872 shares, as per the data available with National Stock Exchange (NSE)
The company reported a constant rise in revenue over the past five years. Its net revenue from operations for the year ended March 31, 2016, stood at around Rs 623.2 crore, witnessing a rise of around 11% on Y-o-Y basis. Net profit for the year ended March 31, 2016, stood at approximately Rs 137.97 crore, witnessing a rise of 65% on Y-o-Y basis.
Expected healthy growth
